Lantheus Holdings Current Ratio 2013-2019 | LNTH
Lantheus Holdings current ratio from 2013 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Lantheus Holdings Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2019-09-30 | $0.15B | $0.06B | 2.59 |
| 2019-06-30 | $0.14B | $0.05B | 2.62 |
| 2019-03-31 | $0.20B | $0.04B | 4.57 |
| 2018-12-31 | $0.20B | $0.05B | 3.70 |
| 2018-09-30 | $0.19B | $0.06B | 3.50 |
| 2018-06-30 | $0.17B | $0.04B | 3.86 |
| 2018-03-31 | $0.16B | $0.05B | 3.51 |
| 2017-12-31 | $0.15B | $0.05B | 3.16 |
| 2017-09-30 | $0.14B | $0.05B | 2.96 |
| 2017-06-30 | $0.13B | $0.04B | 2.92 |
| 2017-03-31 | $0.11B | $0.04B | 2.73 |
| 2016-12-31 | $0.11B | $0.04B | 2.53 |
| 2016-09-30 | $0.11B | $0.04B | 2.82 |
| 2016-06-30 | $0.11B | $0.03B | 3.32 |
| 2016-03-31 | $0.10B | $0.03B | 3.18 |
| 2015-12-31 | $0.09B | $0.04B | 2.53 |
| 2015-09-30 | $0.08B | $0.03B | 2.43 |
| 2015-06-30 | $0.08B | $0.04B | 2.10 |
| 2015-03-31 | $0.00B | 0.00 | |
| 2014-12-31 | $0.00B | 0.00 | |
| 2014-09-30 | $0.00B | 0.00 | |
| 2014-06-30 | $0.00B | 0.00 | |
| 2013-12-31 | $0.08B | $0.06B | 1.42 |
| 2012-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.794B | $0.343B |
| Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $148.956B | 20.58 |
| Abbott Laboratories (ABT) | United States | $148.320B | 27.06 |
| Stryker (SYK) | United States | $74.970B | 25.21 |
| Boston Scientific (BSX) | United States | $60.924B | 28.76 |
| Baxter (BAX) | United States | $41.636B | 25.25 |
| Essilor Luxottica (ESLOY) | France | $33.188B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $30.178B | 18.93 |
| Terumo (TRUMY) | Japan | $26.560B | 33.15 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.341B | 0.00 |
| Coloplast (CLPBY) | Denmark | $25.099B | 38.73 |
| ResMed (RMD) | United States | $21.470B | 39.61 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.270B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $19.151B | 0.00 |
| Insulet (PODD) | United States | $11.169B | 531.35 |
| Bio-Rad Laboratories (BIO) | United States | $10.705B | 51.38 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.616B | 0.00 |
| William Demant Holdings (WILYY) | Denmark | $7.531B | 0.00 |
| Canopy Growth (CGC) | Canada | $7.421B | 0.00 |
| Perrigo (PRGO) | Ireland | $7.212B | 13.45 |
| Hill-Rom Holdings (HRC) | United States | $7.115B | 20.98 |
| Haemonetics (HAE) | United States | $5.955B | 40.24 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.743B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.276B | 27.26 |
| NuVasive (NUVA) | United States | $3.869B | 30.46 |
| ICU Medical (ICUI) | United States | $3.704B | 24.15 |
| Neogen (NEOG) | United States | $3.501B | 58.58 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.090B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $2.969B | 0.00 |
| Quidel (QDEL) | United States | $2.961B | 28.10 |
| Aurora Cannabis (ACB) | Canada | $2.855B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $2.471B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.404B | 54.25 |
| Cardiovascular Systems (CSII) | United States | $1.562B | 0.00 |
| InMode (INMD) | Israel | $1.365B | 0.00 |
| Aphria (APHA) | $1.278B | 0.00 | |
| AtriCure (ATRC) | United States | $1.204B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.154B | 23.11 |
| Phibro Animal Health (PAHC) | United States | $0.983B | 18.41 |
| NanoString Technologies (NSTG) | United States | $0.937B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.924B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.777B | 29.75 |
| Quanterix (QTRX) | United States | $0.701B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.686B | 38.53 |
| PetIQ (PETQ) | United States | $0.685B | 16.70 |
| Omeros (OMER) | United States | $0.654B | 0.00 |
| HEXO (HEXO) | $0.589B | 0.00 | |
| Surmodics (SRDX) | United States | $0.555B | 57.72 |
| Cerus (CERS) | United States | $0.543B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.487B | 29.22 |
| Owens & Minor (OMI) | United States | $0.484B | 17.91 |
| MacroGenics (MGNX) | United States | $0.481B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.420B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.400B | 13.77 |
| Utah Medical Products (UTMD) | United States | $0.384B | 27.83 |
| BioLife Solutions (BLFS) | United States | $0.320B | 130.50 |
| Zynex (ZYXI) | United States | $0.313B | 35.44 |
| Bovie Medical (APYX) | United States | $0.271B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.261B | 0.00 |
| United Health Products (UEEC) | United States | $0.246B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.239B | 25.20 |
| Repro-Med Systems (KRMD) | United States | $0.235B | 0.00 |
| Vapotherm (VAPO) | United States | $0.226B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.178B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.172B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.158B | 796.00 |
| Chimerix (CMRX) | United States | $0.155B | 0.00 |
| Female Health (VERU) | United States | $0.151B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.141B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.127B | 8.98 |
| Cytosorbents (CTSO) | United States | $0.122B | 0.00 |
| United-Guardian (UG) | United States | $0.090B | 22.77 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.073B | 0.00 |
| Nephros (NEPH) | United States | $0.065B | 0.00 |
| MRI Interventions (MRIC) | United States | $0.061B | 0.00 |
| Surface Oncology (SURF) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.024B | 0.00 |
| Senestech (SNES) | United States | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.015B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.014B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.012B | 0.00 |
| Myomo (MYO) | United States | $0.008B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.006B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |
